Related Experiment Video
Updated: Feb 12, 2026

Novel Percutaneous Approach for Deployment of 3D Printed Coronary Stenosis Implants in Swine Models of Ischemic Heart Disease
Published on: February 18, 2020
Kawasaki disease: multiple giant coronary aneurysms intervention and pacemaker implantation due to complete heart
Chunping Liu1, Junxia Li1, Zhenshuang Cui1
1Department of Cardiovascular Disease, General Hospital of PLA Army, Beijing 100700, China.
Insights
Early treatment for Kawasaki disease (KD) is crucial. This case highlights severe complications like giant coronary artery aneurysms and heart block in a patient with delayed diagnosis and treatment.
Area of Science:
- Pediatrics
- Cardiology
- Immunology
Background:
- Kawasaki disease (KD) requires early intravenous immunoglobulin (IVIG) to prevent coronary artery aneurysms (CAAs).
- Delayed diagnosis or atypical presentations, common in rural areas, increase complication risk.
- Effective management of giant CAAs compromising cardiac function remains challenging.
Observation:
- A 19-month-old girl presented with atypical symptoms, leading to delayed KD diagnosis and IVIG treatment.
- She developed multivessel giant CAAs (>8 mm), acute myocardial infarction, and complete heart block.
- Percutaneous coronary intervention (PCI) was unsuccessful in restoring flow to the affected coronary artery.
Findings:
- Despite late IVIG, the patient experienced severe cardiac complications, including giant CAAs and myocardial infarction.
- Persistent bradycardia necessitated permanent pacemaker implantation.
- The patient demonstrated clinical stability at 12-month follow-up post-pacemaker insertion.
Implications:
- This case underscores the critical need for timely KD diagnosis and treatment, especially in atypical or remote cases.
- It highlights the limitations of standard treatments in managing severe, giant CAAs and associated cardiac dysfunction.
- The successful management with a pacemaker suggests a viable option for long-term cardiac support in such complex pediatric cases.
Abstract:
Early intravenous immunoglobulin (IVIG) is the standard treatment for Kawasaki disease (KD) to reduce the incidence of coronary aneurysms. Patients with atypical presentation or who live in a rural area are less likely to receive treatment in the early stage of presentation and are more likely to develop severe complications. There is little consensus on how to treat coronary aneurysms effectively in the acute or subacute stage especially when giant aneurysms develop that compromise cardiac function. This case study is of a 19-month-old girl who initially was not treated as KD and developed multivessel giant coronary artery aneurysms (CAAs) (>8 mm), acute myocardial infarction, and complete heart block despite late intravenous IVIG administration. Multiple attempts of percutaneous coronary intervention (PCI) failed to open the occlusion in the right artery; therefore, bradycardia persisted. The girl received a permanent pace-maker and was doing well at 12-month follow up.
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Heart Failure VII: Nursing Interventions
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Coronary Artery Disease V: Interprofessional Care
Rheumatic Heart Disease I: Introduction

